Regulation - Vibativ

Filter

Current filters:

Vibativ

Popular Filters

Mixed FDA panel vote for Theravance's Vibativ for nosocomial pneumonia

03-12-2012

US drug developer Theravance (Nasdaq: THRX) saw its shares rise more than 5% $22.48 by close of trading…

Antibiotics and Infectious diseasesPharmaceuticalRegulationTheravanceVibativ

Back to top